- Home
- WDC vs GSK Comparison
WDC vs GSK Comparison
Compare WDC & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WDC | GSK |
|---|---|---|
| Founded | 1970 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | 66841 |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.4B | 116.3B |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | WDC | GSK |
|---|---|---|
| Price | $363.19 | $59.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 22 | 2 |
| Target Price | ★ $251.64 | N/A |
| AVG Volume (30 Days) | ★ 7.5M | 3.9M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | 0.14% | ★ 2.95% |
| EPS Growth | ★ 296.17 | N/A |
| EPS | ★ 7.82 | N/A |
| Revenue | ★ $9,520,000,000.00 | N/A |
| Revenue This Year | $32.13 | $6.70 |
| Revenue Next Year | $26.89 | $4.22 |
| P/E Ratio | $46.71 | ★ $32.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $35.51 | $35.08 |
| 52 Week High | $366.30 | $61.70 |
Technical Indicators
Market Signals| Indicator | WDC | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 65.34 | 64.88 |
| Support Level | $246.63 | $47.89 |
| Resistance Level | N/A | $60.37 |
| Average True Range (ATR) | 18.51 | 0.95 |
| MACD | 6.42 | 0.51 |
| Stochastic Oscillator | 89.69 | 86.51 |
Price Performance
Historical ComparisonAbout WDC Western Digital Corporation
Western Digital is a leading vertically integrated supplier of hard disk drives. The HDD market is a practical duopoly, with Western Digital and Seagate being the two largest players. Western Digital designs and manufactures its HDDs, with much of the manufacturing and workforce located in Asia. The primary consumers of HDDs are data centers.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.